Антирак груди. Джейн Плант
Чтение книги онлайн.
Читать онлайн книгу Антирак груди - Джейн Плант страница 57
65
Pugh, R. H., 1981. Allergy to Cows' Milk Protein. Health Visitor, Vol. 54, 231–233.
66
Scon, F. W., 1990. Cow milk and insulin-dependent diabetes mellitus: is there a relationship? Am. J. Clin. Nutr., 51, 489–491.
67
Bahna, S. L., 1987. Milk allergy in infancy. Ann Allergy, 59, 131.
68
Dunea, G., 1982. Beyond the Etheric. Br. Med. J., 285, 428–429.
69
Kretchmer, N., 1981. The Significance of lactose intolerance. In: Paige, D. M. and Bayless, T. M., Eds., Lactose Digestion: Clinical and nutritional implications, Johns Hopkins University Press.
70
Chiodini, R. J. and Hermon-Taylor, J., 1993. The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurisation. J. Vet. Diagn. Invest., 5, 629–631 and Grant, I. R., Ball, H. J., and Rowe, M. T., 1996. Inactivation of Mycobacterium paratuberculosis in cows' milk at pasteurisation temperatures. Appl. And Env. Microbiology, 62, 631–636.
71
The Institute of Food Science & Technology Position Statement, 1998. Food Science Of Technology Today. 12 (4), 223–228, September, http://www.ifst.org/hottop23.html
72
Financial Times for the weekend 20–21 November 1999.
73
The Institute of Food Science & Technology Position Statement. http://www.ifst.org/hottop2.html. Hard copies available from IFST, 5 Cambridge Court, 210 Shepherds Bush Road, London, W6 7NJ.
74
EU Directive 70/524 February 1999.
75
US FDA websites: http://vm.cfsan.fda.gov/~ear/m190-11.html; http://vm.cfsan.fda.gov/~ear/
76
Ingersoll, Bruce, 1990. Technology and Health: FDA Detects Drugs in Milk but Fails to Confirm Results. Wall Street Journal, 6 February p. 86; Ingersoll, Bruce, 1990. Politics and Policy: GAO Says FDA Can't Substantiate Claims About Milk. Wall Street Journal, 21 November p. A16; and Ingersoll, Bruce, 1990. Technology & Health: FDA Plans a Nationwide Test of Milk for Antibiotics, Other Drug Residues. Wall Street Journal, 28 December p. 10.
77
European Commission, Scientific Committee on Veterinary Measures relating to Public Health, 1999. Report on Public Health Aspects of the Use of Bovine Somatotropin, 15–16 March.
78
Cutwater, J. L. and others, 1997. Dairy Products and Breast Cancer: the IGF-1, estrogen and bGH hypothesis, Medical Hypotheses, 48, 453–461.
79
ДДТ (дихлордифенилтрихлорэтан) – один из самых известных пестицидов.
80
The Guardian, 13 July 1999.
81
McCusker, R. H., 1998. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J. Dairy Sci., 81, 1790–1800.
82
Гормон роста, или соматотропин, структурно различается у разных видов животных, поэтому его называют согласно виду, которому он принадлежит, – бычий, свиной или, например, человеческий.
83
The Institute of Food Science & Technology Position Statement http://www.easynet.co.uk/ifst/hottop8a.htm
84
Eppard, P. J. and others, 1985. Effect of dose of bovine growth hormone on milk consumption: alpha-lactalbumin, fatty acids and mineral elements. J. Dairy Science Vol. 68 (11), pp. 3047–3054. See also Cohick, W. S. and others, 1992. Regulation of insulin-like growth factor-binding proteins in serum and lymph of lactating cows by somatotropin. Endocrinology, 130(3), pp. 1508–1514.
85
Mepham, T. B. and others, 1994. Safety of Milk from Cows Treated with Bovine Somatotropin. Lancet, 334, November 19, 1445–1446 and Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.
86
Simpson and others, http://www.nal.usda.gov/ttic/tekran/glimpse/data/000007/75/0000077539.html
87
Miller, M. A., Hildebrand, J. R., White, T. C., Hammond, E. G., Madson, K. S., and Collier, R. J., 1989. Determination of insulin-like growth factor-1 (IGF-1) concentrations in raw pasteurised and heat treated milk. Journal of Dairy Science, 72, Supplement 1, 186–187.
88
Hankinson, Susan E. and others, 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 9113, 9 May, 1393–1396.
89
Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk; A Prospective Study. Science, 279, January.
90
Pollack, M. N., Huynh, H. T. and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100.
91